Glycoprotein IIb/IIIa Inhibition as an Adjunct to Rescue Angioplasty after Failed Fibrinolysis John A. SallachAdam B. Greenbaum OriginalPaper Pages: 5 - 9
Myocardial Infarction in Patients with Normal Coronary Arteries: Proposed Pathogenesis and Predisposing Risk Factors Sean P. PinneyLeRoy E. Rabbani OriginalPaper Pages: 11 - 17
Antithrombotic Effect of LB-30057 (CI-1028), a New Synthetic Thrombin Inhibitor, in a Rabbit Model of Thrombosis: Comparison with Inogatran Liguo ChiThomas E. MertzKim P. Gallagher OriginalPaper Pages: 19 - 31
Trousseau's Syndrome Treated with Long-Term Subcutaneous Lepirudin (Case Report and Review of the Literature) Astrid C. M. AndreescuMary CushmanMarie E. Wood OriginalPaper Pages: 33 - 37
Pharmacokinetics and Pharmacodynamics of Low-Molecular-Weight Heparins and Glycoprotein IIb/IIIa Receptor Antagonists in Renal Failure Brian S. SmithPritesh J. Gandhi OriginalPaper Pages: 39 - 48
Candidate Genes and Confirmed Genetic Polymorphisms Associated with Cardiovascular Diseases: A Tabular Assessment Zhonghua TangRussell P. Tracy OriginalPaper Pages: 49 - 81
Platelet Glycoprotein IIb/IIIa Inhibitors Combined with Fibrinolytic Agents to Treat Acute Myocardial Infarction Philippe L. L'AllierA. Michael Lincoff OriginalPaper Pages: 83 - 91